Dyne Therapeutics (DYN)
NASDAQ:DYN
US Market
Holding DYN?
Track your performance easily

Dyne Therapeutics (DYN) Ownership - Who Owns Dyne Therapeutics?

286 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 10, 2024
Richard William Scalzo
Svp, Head Of Finance & Admin
xxxxxxxxxxxxx
$4052851
Sep 04, 2024
John Cox
Ceo & President,director
xxxxxxxxxxxxx
$1057216
Mar 13, 2024
xxxxxxxxxxxxx
$725344
Mar 13, 2024
xxxxxxxxxxxxx
$2815712

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
6,049,204Institution6.03%207,729,665
4,339,243Institution4.32%149,009,605
3,732,065Institution3.72%128,159,112
3,672,931Institution3.66%126,128,451
1,633,432Institution1.63%56,092,055
1,584,050Institution1.58%54,396,277
1,312,414Institution1.31%45,068,297
1,290,540Institution1.29%44,317,144
1,233,908Institution1.23%42,372,401
1,196,034Institution1.19%41,071,808

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,732,065Institution3.72%128,159,112
1,584,050Institution1.58%54,396,277
1,312,414Institution1.31%45,068,297
1,290,540Institution1.29%44,317,144
1,196,034Institution1.19%41,071,808
1,088,284Institution1.08%37,371,673
963,634Institution0.96%33,091,192
892,923Institution0.89%30,662,976
686,029Institution0.68%23,558,236
662,251Institution0.66%22,741,699

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,620,098Institution2.61%112,428,405
2,166,491Institution2.16%74,397,301
1,523,185Institution1.52%52,702,201
1,111,610Institution1.11%47,699,185
714,506Institution0.71%24,536,136
462,148Institution0.46%15,870,162
317,784Institution0.32%13,636,111
344,035Institution0.34%11,903,611
180,162Institution0.18%7,730,751
126,881Institution0.13%4,357,094

FAQ

Who Owns Dyne Therapeutics (DYN)?
Currently, no data Available
What percentage of Dyne Therapeutics (DYN) stock is held by institutional investors?
Currently, no data Available
What percentage of Dyne Therapeutics (DYN) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Dyne Therapeutics (DYN)?
Peter Kolchinsky owns the most shares of Dyne Therapeutics (DYN).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis